Global Constipation Treatment Market: Scope and Methodology
This report on the global constipation treatment market analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments.
The research is a combination of primary and secondary research. Primary research formed the bulk of our research efforts along with information collected from telephonic interviews and interactions via e-mails. Secondary research involved study of company websites, annual reports, press releases, stock analysis presentations, and various international and national databases. The report provides market size in terms of US$ Mn for each segment and sub-segment for the period from 2017 to 2025, considering the macro and micro environmental factors. Growth rates for each segment within the global constipation treatment market have been determined after a thorough analysis of past trends, demographics, future trends, technological developments, and regulatory requirements.
A detailed qualitative analysis of factors responsible for driving and restraining market growth and future opportunities has been provided in the market overview section. This section of the report also includes market attractiveness analysis that provides a thorough analysis of the overall competitive scenario in the global constipation treatment market.
Market revenue in terms of US$ Mn for the period between 2015 and 2025 along with the compound annual growth rate (CAGR %) from 2017 to 2025 are provided for all the segments, considering 2016 as the base year and 2015 as historic year. Market size estimations involved in-depth study of product features of different types of therapeutic options and various pipeline products. Additionally, market related factors such as preference for self-medication, regional availability of specialty drugs, projected launch of new drugs etc. in various geographies and historical year-on-year growth have been taken into consideration while estimating the market size.
Request a PDF of Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=16442
Constipation treatment Market: Segmentation
Constipation is common disease which is estimated to affect each individual once in life time. According to international as well regional guidelines it is characterized by frequency and nature of bowel movement. Less than 2 bowel movements per week, associated with hard stool and strain in passing is termed as constipation. Constipation may be occasional which lasts for few weeks or may be chronic which lasts for longer period and is recurrent. It may be associated with other conditions such as irritable bowel syndrome or opioid consumption.
Based on therapeutic option, the global constipation treatment market has been segmented into laxatives, chloride channel activators, peripherally acting mu opioid receptor antagonists, GC-C agonists and 5-HT4 receptor agonists. The laxatives segment is further classified into bulk forming agents, osmotic laxatives, stimulant laxatives, and others. The laxatives segment is anticipated to hold a dominating share of the global market. The GC-C agonists segment is projected to have exponential growth during the forecast period due to efficacy and launch of new products.
Based on disease type, the global constipation treatment market is segmented into chronic idiopathic constipation (CIC), irritable bowel syndrome with constipation (IBS-C) and opioid induced constipation (OIC). High prevalence of chronic constipation is estimated to contribute for dominating share of CIC segment in global market while increasing opioid consumption is projected to propel for exponential growth of OIC segment during forecast period.
Based on the distribution channel, the global constipation treatment market is segmented into hospital pharmacies, retail pharmacies and online pharmacies. Ever increasing number of retail pharmacies, self-medication with widely available OTC laxatives is attributed for the significant share of the segment in the global market.
Constipation treatment Market: Geographical and Competitive Dynamics
Geographically, the global constipation treatment market has been segmented into six regions: North America, Europe, Asia Pacific, Latin America, Middle East & Africa and Commonwealth of Independent States. In addition, the regions have been further segmented by major countries from each region.
The report also profiles major players in the constipation treatment market based on various attributes such as company overview, financial overview, SWOT analysis, key business strategies, product portfolio, and recent developments. Key companies profiled in the report include Ironwood Pharmaceuticals, Inc., Sucampo Pharmaceuticals, Inc., Synergy Pharmaceuticals, Inc., Takeda Pharmaceuticals Company Limited, Valeant Pharmaceuticals International, Inc., Abbott Laboratories, AstraZeneca, Valeant Pharmaceuticals International, Inc., Cosmo Pharmaceuticals NV, Sanofi, Daewoong Pharmaceuticals Co. Ltd., Bayer AG, Prestige Brands Holdings, Inc., Janssen Pharmaceutical Company, Shionogi & Co., Ltd., Albireo Pharma, Inc., and Renexxion, LLC.
Request for Customization in Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=16442
This post was originally published on The Market Plan